Question 1

Was ist der Wirkstoff in SARS-CoV-2 VIRUS RECOMBINANT SPIKE (S) PROTEIN RECEPTOR BINDING DOMAIN (RBD) FUSION HOMODIMER-OMICRON LP.8.1 / LP.8.1 VARIANT?

Accepted Answer

SARS-CoV-2 VIRUS RECOMBINANT SPIKE (S) PROTEIN RECEPTOR BINDING DOMAIN (RBD) FUSION HOMODIMER-OMICRON LP.8.1 /  LP.8.1 VARIANT

Question 2

In welcher Darreichungsform ist SARS-CoV-2 VIRUS RECOMBINANT SPIKE (S) PROTEIN RECEPTOR BINDING DOMAIN (RBD) FUSION HOMODIMER-OMICRON LP.8.1 / LP.8.1 VARIANT erhältlich?

Accepted Answer

SARS-CoV-2 VIRUS RECOMBINANT SPIKE (S) PROTEIN RECEPTOR BINDING DOMAIN (RBD) FUSION HOMODIMER-OMICRON LP.8.1 / LP.8.1 VARIANT: Emulsie voor injectie (Intramusculair gebruik)

Question 3

Wer stellt SARS-CoV-2 VIRUS RECOMBINANT SPIKE (S) PROTEIN RECEPTOR BINDING DOMAIN (RBD) FUSION HOMODIMER-OMICRON LP.8.1 / LP.8.1 VARIANT her?

Accepted Answer

Hipra Human Health, S.L.U. (NL)

Question 4

Zu welcher ATC-Klasse gehört SARS-CoV-2 VIRUS RECOMBINANT SPIKE (S) PROTEIN RECEPTOR BINDING DOMAIN (RBD) FUSION HOMODIMER-OMICRON LP.8.1 / LP.8.1 VARIANT?

Accepted Answer

SARS-CoV-2 VIRUS RECOMBINANT SPIKE (S) PROTEIN RECEPTOR BINDING DOMAIN (RBD) FUSION HOMODIMER-OMICRON LP.8.1 / LP.8.1 VARIANT: ATC J07BN04. ATC ist die anatomisch-therapeutisch-chemische WHO-Klassifikation — gruppiert Medikamente nach Organsystem und Wirkmechanismus.

SARS-CoV-2 VIRUS RECOMBINANT SPIKE (S) PROTEIN RECEPTOR BINDING DOMAIN (RBD) FUSION HOMODIMER-OMICRON LP.8.1 / LP.8.1 VARIANT

Nutzerbewertungen